This is the second of 2 one-hour webinars on EGPA, presented by the American Thoracic Society in partnership with AKH Inc. Each is led by 3 experts. The first program addressed foundation information about the diagnosis, treatment initiation and long-term monitoring of this rare eosinophilic disorder. Because EGPA affects many organ systems, a wide range of clinicians may be involved in the diagnosis and management of these patients. This webinar applies the foundational information regarding the diagnosis, treatment initiation, and long-term monitoring of EGPA through a series of case scenarios.
This educational activity is supported by an educational grant from GlaxoSmithKline.